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Background
High-grade [WHO, 2007- grade III-IV] gliomas are
undifferentiated or anaplastic, are highly infiltrating and
termed as malignant. The overall prognosis and survival
rate is very low. Only few highly sensitive and specific
biomarkers for Glioma have been identified, but are yet
to be put for routine use due to challenges in their clini-
cal validation for early disease detection, diagnosis and
monitoring to improve long-term survival of patients.
The inefficacy of currently available chemotherapeutic
and radio-therapeutic agents largely depends on a num-
ber of resistance mechanisms among which DNA repair
plays an important role. Hence bio-molecules involved
in DNA repair mechanisms will be promising biomar-
kers. Current status in the validation of DNA repair
genes include, studying the promoter methylation of the
only direct DNA repair gene O6-methylguanine-DNA
methyltransferase (MGMT). MGMT is epigenetically
inactivated via hypermethylation of the 5′-CpG islands
located in promoter region. It is associated with predic-
tion of successful alkylating agent therapy with temozo-
lomide in combination with radiotherapy and also
longer overall survival in patients. The silenced MGMT
gene possibly enhances radiation effects by inducing
radiation-mediated double stranded DNA (dsDNA)
breaks and suppression of dsDNA repair pathways after
radiation exposure.
Materials & methods
Post surgery excised tumor samples from 20 patients
diagnosed histopathologically with high grade glioma
were tested for MGMT promoter region methylation
status. DNA extraction and bisulphate conversion using
suitable commercially available kits (Qiagen) followed by
Methylation specific PCR using specific methylated and
unmethylated primers was carried out. Correlations are
underway with clinical profile and treatment regimen.
Results
Hypermethylation of the promoter region was observed
in about 60%, (12) samples. The other samples only
demonstrated unmethylated regions.
Conclusions
Assessment of promoter methylation of the MGMT
gene helps in the therapeutic choice of the patients. It
has gained importance not only as a prognostic but also
as a predictive biomarker in molecular profiling of high
grade gliomas.
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